- Home
- MGTX vs DFP Comparison
MGTX vs DFP Comparison
Compare MGTX & DFP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGTX
- DFP
- Stock Information
- Founded
- MGTX 2015
- DFP 2013
- Country
- MGTX United States
- DFP United States
- Employees
- MGTX N/A
- DFP N/A
- Industry
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- DFP Investment Managers
- Sector
- MGTX Health Care
- DFP Finance
- Exchange
- MGTX Nasdaq
- DFP Nasdaq
- Market Cap
- MGTX 479.9M
- DFP 418.2M
- IPO Year
- MGTX N/A
- DFP N/A
- Fundamental
- Price
- MGTX $6.26
- DFP $20.39
- Analyst Decision
- MGTX Strong Buy
- DFP
- Analyst Count
- MGTX 2
- DFP 0
- Target Price
- MGTX $23.50
- DFP N/A
- AVG Volume (30 Days)
- MGTX 337.9K
- DFP 56.2K
- Earning Date
- MGTX 03-13-2025
- DFP 01-01-0001
- Dividend Yield
- MGTX N/A
- DFP 6.73%
- EPS Growth
- MGTX N/A
- DFP N/A
- EPS
- MGTX N/A
- DFP N/A
- Revenue
- MGTX $13,929,000.00
- DFP N/A
- Revenue This Year
- MGTX N/A
- DFP N/A
- Revenue Next Year
- MGTX $1,391.84
- DFP N/A
- P/E Ratio
- MGTX N/A
- DFP N/A
- Revenue Growth
- MGTX 108.24
- DFP N/A
- 52 Week Low
- MGTX $3.85
- DFP $15.45
- 52 Week High
- MGTX $7.37
- DFP $19.31
- Technical
- Relative Strength Index (RSI)
- MGTX 53.41
- DFP 54.99
- Support Level
- MGTX $5.66
- DFP $19.85
- Resistance Level
- MGTX $6.12
- DFP $20.45
- Average True Range (ATR)
- MGTX 0.39
- DFP 0.22
- MACD
- MGTX -0.02
- DFP 0.05
- Stochastic Oscillator
- MGTX 62.26
- DFP 85.54
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.
About DFP Flaherty & Crumrine Dynamic Preferred and Income Fund Inc.
Flaherty & Crumrine Pref&Inc Allocation is a diversified, closed-end management investment company. Its investment objective is to seek total return, with an emphasis on high current income.